Dr Susan Gale-Phillips

Susan Gale-PhillipsSusan completed her PhD studies in Biochemistry at the University of Adelaide, and has enjoyed approximately 28 years working in the biotechnology, technology and pharmaceutical industries in Australia, USA and the UK. Since completing her postdoctoral fellowship at Chiron Corporation (California, USA) in 1989, Susan has held several commercial roles involving business development, sales and marketing, legal and intellectual property management. Notably, she held the role of Senior Director of Commercial Operations at the drug discovery service company “BioFocus Ltd” in Cambridge UK from 2005 - 2010 before becoming a senior team leader at Oxford University Innovation Ltd (formerly known as “Isis Innovation”), the technology transfer company of the University of Oxford. Her achievements include the founding of an in vitro diagnostics distribution company in 1999, and more recently, the creation of 2 new successful spin-out companies from the University of Oxford, namely Oxford Cancer Biomarkers Ltd http://www.oxfordbio.com and Oxehealth Ltd http://www.oxehealth.com).